Lu Kang Pharmaceutical (600789.SH): Injectable Vancomycin hydrochloride is expected to be selected for national centralized drug procurement.

Zhitong Finance APP reported that Lukan Pharmaceutical (600789.SH) issued an announcement stating that the company recently participated in the bidding process organized by the National Organization for Drug Procurement Office for the 12th batch of national centralized drug procurement. The company's product, Injection Vancomycin Hydrochloride (0.5g (500,000 units)), is expected to be selected in this centralized procurement.